Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Long Term Debt

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Long-Term-Debt" stands at 4.35 Trillion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Long Term Debt" stands at 4.35 Trillion JPY. This represents an increase of 5.24 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -1.71 percent compared to the value the year prior.
The 1 year change in percent is -1.71.
The 3 year change in percent is 4.39.
The 5 year change in percent is -6.04.
The 10 year change in percent is 591.75.

The Serie's long term average value is 2.97 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 46.60 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2011, to it's latest available value, on 09/30/2025, is +28,647.19%.
The Serie's change in percent from it's maximum value, on 06/30/2019, to it's latest available value, on 09/30/2025, is -15.21%.

Long Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Long Term Debt905,699,262,464.00
LogoJohnson & Johnson - Long Term Debt486,508,953,600.00
LogoAbbVie Inc - Long Term Debt399,570,305,024.00
LogoRoche Holding AG - Long Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Long Term Debt280,205,508,085.11